TrialJournal of immunotherapy (Hagerstown, Md. : 1997)

Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma.

Peter Attia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.